- Home
- TYRA vs PUMP Comparison
TYRA vs PUMP Comparison
Compare TYRA & PUMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYRA
- PUMP
- Stock Information
- Founded
- TYRA 2018
- PUMP 2007
- Country
- TYRA United States
- PUMP United States
- Employees
- TYRA N/A
- PUMP N/A
- Industry
- TYRA Biotechnology: Pharmaceutical Preparations
- PUMP Oilfield Services/Equipment
- Sector
- TYRA Health Care
- PUMP Energy
- Exchange
- TYRA Nasdaq
- PUMP Nasdaq
- Market Cap
- TYRA 576.6M
- PUMP 550.9M
- IPO Year
- TYRA 2021
- PUMP 2017
- Fundamental
- Price
- TYRA $10.47
- PUMP $6.56
- Analyst Decision
- TYRA Strong Buy
- PUMP Buy
- Analyst Count
- TYRA 7
- PUMP 5
- Target Price
- TYRA $30.86
- PUMP $9.75
- AVG Volume (30 Days)
- TYRA 364.1K
- PUMP 1.9M
- Earning Date
- TYRA 08-06-2025
- PUMP 07-30-2025
- Dividend Yield
- TYRA N/A
- PUMP N/A
- EPS Growth
- TYRA N/A
- PUMP N/A
- EPS
- TYRA N/A
- PUMP N/A
- Revenue
- TYRA N/A
- PUMP $1,397,859,000.00
- Revenue This Year
- TYRA N/A
- PUMP N/A
- Revenue Next Year
- TYRA N/A
- PUMP $9.57
- P/E Ratio
- TYRA N/A
- PUMP N/A
- Revenue Growth
- TYRA N/A
- PUMP N/A
- 52 Week Low
- TYRA $6.42
- PUMP $4.61
- 52 Week High
- TYRA $29.60
- PUMP $11.17
- Technical
- Relative Strength Index (RSI)
- TYRA 58.12
- PUMP 57.76
- Support Level
- TYRA $9.93
- PUMP $6.42
- Resistance Level
- TYRA $10.49
- PUMP $6.71
- Average True Range (ATR)
- TYRA 0.59
- PUMP 0.30
- MACD
- TYRA 0.08
- PUMP 0.02
- Stochastic Oscillator
- TYRA 94.30
- PUMP 76.79
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.